PURPOSE: This retrospective review was conducted to identify prognostic factors for two-stage reimplantation for infected total knee arthroplasty (TKA) and the rate of reinfection following revision TKA. MATERIALS AND METHODS: Out of 88 patients diagnosed with post-TKA infection between 1998 and 2011, 76 underwent two-stage reimplantation and were reviewed in this study. The 76 patients were divided into two groups-those who experienced reinfection and those who did not. Comorbidities, culture results, and inflammation indices were analyzed and compared between the two groups. RESULTS: Of the 76 patients who underwent a two-stage reimplantation, 18 (23.7%) experienced reinfection. Patients with more than three comorbidities had significantly higher reinfection rates than those with less than three comorbidities (47.1% vs. 4.8%, p=0.032). The reinfection rate between the culture positive prosthetic joint infection group and the culture negative prosthetic joint infection group was not significantly different (p=0.056). Inflammation indices (erythrocyte sedimentation rate [ESR] and C-reactive protein [CRP]) showed a statistically significant difference between patients with reinfection and those without reinfection at 4 weeks after the first-stage surgery. CONCLUSIONS: Reimplantation must be carefully performed when the risk of reinfection is high, particularly in patients with more than three systemic or local comorbidities and higher inflammation indices (ESR and CRP) prior to revision TKA.
PURPOSE: This retrospective review was conducted to identify prognostic factors for two-stage reimplantation for infected total knee arthroplasty (TKA) and the rate of reinfection following revision TKA. MATERIALS AND METHODS: Out of 88 patients diagnosed with post-TKA infection between 1998 and 2011, 76 underwent two-stage reimplantation and were reviewed in this study. The 76 patients were divided into two groups-those who experienced reinfection and those who did not. Comorbidities, culture results, and inflammation indices were analyzed and compared between the two groups. RESULTS: Of the 76 patients who underwent a two-stage reimplantation, 18 (23.7%) experienced reinfection. Patients with more than three comorbidities had significantly higher reinfection rates than those with less than three comorbidities (47.1% vs. 4.8%, p=0.032). The reinfection rate between the culture positive prosthetic joint infection group and the culture negative prosthetic joint infection group was not significantly different (p=0.056). Inflammation indices (erythrocyte sedimentation rate [ESR] and C-reactive protein [CRP]) showed a statistically significant difference between patients with reinfection and those without reinfection at 4 weeks after the first-stage surgery. CONCLUSIONS: Reimplantation must be carefully performed when the risk of reinfection is high, particularly in patients with more than three systemic or local comorbidities and higher inflammation indices (ESR and CRP) prior to revision TKA.
Authors: Bernd Kubista; Robert U Hartzler; Christina M Wood; Douglas R Osmon; Arlen D Hanssen; David G Lewallen Journal: Int Orthop Date: 2011-05-07 Impact factor: 3.075
Authors: Javad Parvizi; Khalid Azzam; Elie Ghanem; Matthew S Austin; Richard H Rothman Journal: Clin Orthop Relat Res Date: 2009-05-01 Impact factor: 4.176
Authors: Elie F Berbari; Camelia Marculescu; Irene Sia; Brian D Lahr; Arlen D Hanssen; James M Steckelberg; Rachel Gullerud; Douglas R Osmon Journal: Clin Infect Dis Date: 2007-09-26 Impact factor: 9.079
Authors: Michael Drexler; Tim Dwyer; Paul R T Kuzyk; Yona Kosashvilli; Mansour Abolghasemian; Gilad J Regev; Assaf Kadar; Tal Frenkel Rutenberg; David Backstein Journal: Knee Surg Sports Traumatol Arthrosc Date: 2015-08-14 Impact factor: 4.342
Authors: Jaiben George; Suparna M Navale; Nicholas K Schiltz; Miguel Siccha; Alison K Klika; Carlos A Higuera Journal: Clin Orthop Relat Res Date: 2017-07 Impact factor: 4.176
Authors: Mustafa Akkaya; Georges Vles; Iman Godarzi Bakhtiari; Amir Sandiford; Jochen Salber; Thorsten Gehrke; Mustafa Citak Journal: Int Orthop Date: 2022-01-04 Impact factor: 3.075
Authors: Y Inagaki; Y Uchihara; M Munemoto; M Scarborough; C A F Dodd; C L M H Gibbons; Y Tanaka; N A Athanasou Journal: Arch Orthop Trauma Surg Date: 2019-03-11 Impact factor: 3.067
Authors: Steffen Hoell; Anna Sieweke; Georg Gosheger; Jendrik Hardes; Ralf Dieckmann; Helmut Ahrens; Arne Streitbuerger Journal: J Orthop Surg Res Date: 2016-08-26 Impact factor: 2.359
Authors: Maria Dudareva; Andrew Hotchen; Martin A McNally; Jamie Hartmann-Boyce; Matthew Scarborough; Gary Collins Journal: J Bone Jt Infect Date: 2021-07-08